Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 14, 2019

SELL
$8.27 - $12.73 $587,170 - $903,830
-71,000 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$14.31 - $17.65 $186,030 - $229,449
-13,000 Reduced 15.48%
71,000 $1.31 Million
Q2 2018

Aug 10, 2018

SELL
$11.83 - $16.2 $248,430 - $340,200
-21,000 Reduced 20.0%
84,000 $1.61 Million
Q2 2017

Aug 14, 2017

BUY
N/A
105,000
105,000 $1.98 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $539M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Employees Retirement System Of Texas Portfolio

Follow Employees Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Employees Retirement System Of Texas with notifications on news.